Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC

INTRODUCTION: Previous studies have described improvements on lipid parameters when switching from other antiretroviral drugs to tenofovir (TDF) and impairments in lipid profile when discontinuing TDF. [1–3] It is unknown, however, if TDF has an intrinsic lipid-lowering effect or such findings are d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramón Santos, José, Saumoy, María, Curran, Adrian, Bravo, Isabel, Navarro, Jordi, Estany, Carla, Podzamczer, Daniel, Ribera, Esteban, Negredo, Eugenia, Clotet, Bonaventura, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224859/
https://www.ncbi.nlm.nih.gov/pubmed/25394057
http://dx.doi.org/10.7448/IAS.17.4.19550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224859/
https://www.ncbi.nlm.nih.gov/pubmed/25394057
http://dx.doi.org/10.7448/IAS.17.4.19550

Ejemplares similares